Related references
Note: Only part of the references are listed.Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study
E. A. Williams et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation
A. Agrawal et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Randomized Controlled Treatment Trial of Irritable Bowel Syndrome with a Probiotic E.-coli Preparation (DSM17252) Compared to Placebo
P. Enck et al.
ZEITSCHRIFT FUR GASTROENTEROLOGIE (2009)
Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome
J. Zeng et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Review article: probiotics and prebiotics in irritable bowel syndrome
R. Spiller
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Therapeutic effect of Lactobacillus acidophilus-SDC 2012, 2013 in patients with irritable bowel syndrome
Dong Hyun Sinn et al.
DIGESTIVE DISEASES AND SCIENCES (2008)
A meta-analysis on the efficacy of probiotics for maintenance of remission and prevention of clinical and endoscopic relapse in Crohn's disease
Roja Rahimi et al.
DIGESTIVE DISEASES AND SCIENCES (2008)
A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome
S. Drouault-Holowacz et al.
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE (2008)
Clinical trial on the efficacy of a new symbiotic formulation, Flortec, in patients with irritable bowel syndrome - A multicenter, randomized study
Angelo Andriulli et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2008)
A mixture of Escherichia coli (DSM 17252) and Enterococcus faecalis (DSM 16440) for treatment of the irritable bowel syndrome -: A randomized controlled trial with primary care physicians
P. Enck et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2008)
Meta-analysis of probiotics for the treatment of irritable bowel syndrome
Lynne V. McFarland et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Probiotic effects on intestinal fermentation patterns in patients with irritable bowel syndrome
Jacqueline S. Barrett et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota
K. Kajander et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Guidelines on the irritable bowel syndrome: mechanisms and practical management
R. Spiller et al.
GUT (2007)
High-dose probiotics for the treatment of active pouchitis
Paolo Gionchetti et al.
DISEASES OF THE COLON & RECTUM (2007)
Effects of multispecies probiotic supplementation on intestinal microbiota in irritable bowel syndrome
K. Kajander et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care:: a multicentre, randomized, double-blind, controlled trial
D. Guyonnet et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Prescript-Assist™ probiotic-prebiotic treatment for irritable bowel syndrome:: An open-label, partially controlled, 1-year extension of a previously published controlled clinical trial
Alvah C. Bittner et al.
CLINICAL THERAPEUTICS (2007)
Multicenter randomized-control led clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after ileo-caecal resection
Andre Van Gossum et al.
INFLAMMATORY BOWEL DISEASES (2007)
A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1
Jochen Hampe et al.
NATURE GENETICS (2007)
A randomized double-blind placebo-controlled trial of Lactobacillus GG for abdominal pain disorders in children
A. Gawronska et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Bacteria- and host-derived mechanisms to control intestinal epithelial cell homeostasis: Implications for chronic inflammation
Thomas Clovel et al.
INFLAMMATORY BOWEL DISEASES (2007)
Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date
E. M. M. Quigley et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2007)
Prebiotics, probiotics, and dietary fiber in gastrointestinal disease
Jacqueline Park et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2007)
A genome-wide association study identifies IL23R as an inflammatory bowel disease gene
Richard H. Duerr et al.
SCIENCE (2006)
Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome
Peter J. Whorwell et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis
RB Sartor
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2006)
Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease:: a randomised, double blind, placebo controlled GETAID trial
P. Marteau et al.
GUT (2006)
Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis
M. A. Zocco et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis
T. Kuehbacher et al.
GUT (2006)
Functional bowel disorders
George F. Longstreth et al.
GASTROENTEROLOGY (2006)
Design of treatment trials for functional gastrointestinal disorders
E. Jan Irvine et al.
GASTROENTEROLOGY (2006)
The primary defect in experimental ileitis originates from a nonhematopoietic source
TS Olson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
The efficacy of Lactobacillus reuteri ATCC 55730 in the treatment of patients with irritable bowel syndrome -: a double blind, placebo-controlled, randomized study
E Niv et al.
CLINICAL NUTRITION (2005)
Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease
K Yamazaki et al.
HUMAN MOLECULAR GENETICS (2005)
A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating
HJ Kim et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2005)
A randomized, double-blind trial of lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease
A Bousvaros et al.
INFLAMMATORY BOWEL DISEASES (2005)
The use of Lactobacillus GG in irritable bowel syndrome in children:: A double-blind randomized control trial
M Bausserman et al.
JOURNAL OF PEDIATRICS (2005)
VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis
R Bibiloni et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Prescript-assist™ probiotic-prebiotic treatment for irritable bowel syndrome:: A methodologically oriented, 2-week, randomized, placebo-controlled, double-blind clinical study
AC Bittner et al.
CLINICAL THERAPEUTICS (2005)
Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease
DPB McGovern et al.
HUMAN MOLECULAR GENETICS (2005)
Use of diet and probiotic therapy in the irritable bowel syndrome - Analysis of the literature
MH Floch
JOURNAL OF CLINICAL GASTROENTEROLOGY (2005)
Lactobacillus and Bifidobacterium in irritable bowel syndrome:: Symptom responses and relationship to cytokine profiles
L O'Mahony et al.
GASTROENTEROLOGY (2005)
Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis:: a randomised controlled pilot trial
E Furrie et al.
GUT (2005)
Clinical relevance of advances in genetics and pharmacogenetics of IBD
T Ahmad et al.
GASTROENTEROLOGY (2004)
Lactobacillus GG in inducing and maintaining remission of Crohn's disease
M Schultz et al.
BMC GASTROENTEROLOGY (2004)
High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease
A Darfeuille-Michaud et al.
GASTROENTEROLOGY (2004)
Crohn's disease is associated with a toll-like receptor-9 polymorphism
HP Török et al.
GASTROENTEROLOGY (2004)
Probiotics in the treatment of irritable bowel syndrome
A Saggioro
JOURNAL OF CLINICAL GASTROENTEROLOGY (2004)
Deficient host-bacteria interactions in inflammatory bowel disease?: The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis
D Franchimont et al.
GUT (2004)
Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis
K Kato et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis
T Mimura et al.
GUT (2004)
Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine
W Kruis et al.
GUT (2004)
Failure to induce oral tolerance to a soluble protein in patients with inflammatory bowel disease
TA Kraus et al.
GASTROENTEROLOGY (2004)
Genetic variation in DLG5 is associated with inflammatory bowel disease
M Stoll et al.
NATURE GENETICS (2004)
Functional variants of OCTN cation transporter genes are associated with Crohn disease
VD Peltekova et al.
NATURE GENETICS (2004)
Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences
EV Loftus
GASTROENTEROLOGY (2004)
MDR1 Ala893 polymorphism is associated with inflammatory bowel disease
SR Brant et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
The immunological and genetic basis of inflammatory bowel disease
G Bouma et al.
NATURE REVIEWS IMMUNOLOGY (2003)
Inflammatory bowel disease in a Swedish twin cohort:: A long-term follow-up of concordance and clinical characteristics
J Halfvarson et al.
GASTROENTEROLOGY (2003)
Prophylaxis of pouchitis onset with probiotic therapy: A double-blind, placebo-controlled trial
P Gionchetti et al.
GASTROENTEROLOGY (2003)
A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome
HJ Kim et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Effect of Lactobacillus rhamnosus GG on ileal pouch inflammation and microbial flora
J Kuisma et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis
H Ishikawa et al.
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2003)
Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis
M Schwab et al.
GASTROENTEROLOGY (2003)
Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome
S Sen et al.
DIGESTIVE DISEASES AND SCIENCES (2002)
Probiotics and Crohn's disease
C Prantera et al.
DIGESTIVE AND LIVER DISEASE (2002)
Mucosal flora in inflammatory bowel disease
A Swidsinski et al.
GASTROENTEROLOGY (2002)
Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease
JD Rioux et al.
NATURE GENETICS (2001)
A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome
K Niedzielin et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2001)
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
JP Hugot et al.
NATURE (2001)
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Y Ogura et al.
NATURE (2001)
Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk
EJ Irvine et al.
GASTROENTEROLOGY (2000)
Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial
P Gionchetti et al.
GASTROENTEROLOGY (2000)
Saccharomyces boulardii in maintenance treatment of Crohn's disease
M Guslandi et al.
DIGESTIVE DISEASES AND SCIENCES (2000)
Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study
MA O'Sullivan et al.
DIGESTIVE AND LIVER DISEASE (2000)
Share Paper
